JPRN-jRCT1091220086已完成不适用
Study of Infliximab Therapy for IVIG Treatment-resistant Kawasaki Disease. - KAWASAKIINF01
Investigator-initiated Clinical Research (in-house)0 个研究点目标入组 20 人开始时间: 2012年4月24日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients against IVIG Treatment-resistant Kawasaki Disease (less than 37.5 degrees C within a 24-hour period)
排除标准
- •Past History of Demyelinating Disease
- •Patients less than 6 months of taking BCG
- •Patients with lung thberculosis
研究者
相似试验
进行中（未招募）
不适用
Efficacy of IVIG in the treatment of treatment-resistent painful neuropathy - IVIg in neuropathic paiEUCTR2007-007007-32-ITAZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE)
已完成
不适用
The efficacy of intravenous immunoglobulin(IVIG) for the maintenance phase of treatment for children with acute lymphoblastic leukemia(ALL)Acute lymphoblastic leukemiaJPRN-UMIN000015179agoya University Graduate School of Medicine30
已完成
Unknown
Study of Infliximab Therapy for Multiple Treatment(included IVIG)-resistant Kawasaki DiseaseKawasaki DiseaseJPRN-jRCT1091220201Investigator-initiated Clinical Research(in-house)20
进行中（未招募）
1 期
EFFICACI : EFFicacy of intravenous Infliximab versus vedolizumab after failure of subCutaneous Anti-TNF in patients with UlCerative colitis : A double blinded Randomized Clinical Trial.lcerative colitisMedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856EUCTR2018-002673-21-FRCentre Hospitalier Universitaire de Rennes150
已完成
不适用
The No IntraCranial Haemorrhage (NOICH) StudyFoetal or neonatal alloimmune thrombocytopeniaPregnancy and ChildbirthOther perinatal haematological disordersISRCTN29462550eiden University Medical Centre (LUMC) (Netherlands)212